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SALF REGULATES MITOCHONDRIA- AND
CASPASE-DEPENDENT APOPTOTIC PATHWAYS
IN CERVICAL CANCER CELLS
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treatment for cervical cancer, either alone or in combination
with traditional therapies.

ABSTRACT

I. INTRODUCTION

Antimicrobial peptides (AMPs) are a new source of potential anticancer drugs. One such AMP is the shrimp antilipopolysaccharide factor (SALF), an AMP isolated from
Penaeus monodon; the SALF was previously reported to induce tumor cell death. However, the mechanism by which the
SALF regulates these pathways remains unclear. In this study,
we identified that the SALF modulates mitochondria- and
caspase-dependent apoptotic pathways in human cervical cancer cells. The SALF was found to inhibit the growth of four
cervical cancer cell lines: HeLa, HeLa 299, C33A, and Ca
ski. In addition, a fluorescence-activated cell sorting (FACS)
analysis revealed that the SALF induced death and G2/M
phase arrest in HeLa and HeLa 299 cells. The SALF itself
was found to be localized to the cytosol and nuclei of HeLa
cells by confocal imaging. Staining with acridine orange/
ethidium bromide and analysis of DNA fragmentation confirmed that the SALF induced apoptosis in HeLa cells.
Moreover, caspases-3 and -9 were found to be involved in
SALF-induced apoptosis, through the use of various caspase
inhibitors in vitro and immunohistochemistry in vivo. Finally,
the SALF was found to induce depolarization of mitochondrial
membranes with associated translocation of the AIF to nuclei,
and to affect levels of Bcl-2 family proteins in HeLa cells.
Taken together, our findings indicate that the SALF induces
mitochondria- and caspase-dependent apoptotic pathways in
HeLa cells. We suggest that the SALF may be an effective

Antimicrobial peptides (AMPs) play key roles in innate
immunity and display antitumor activities (Zasloff, 2002;
Brown and Hancock, 2006) due to their membrane-destabilizing
and apoptosis-inducing effects (Mader et al., 2005; Mader et
al., 2009). One of the AMPs is a natural shrimp product that
offers hopeful new choices for developing more-effective
chemotherapeutic drugs for cancers. The shrimp anti-lipopolysaccharide factor (SALF) has anti-inflammatory response
functions (Lin et al., 2010a) and anti-cervical cancer properties, and displays minimal toxicity in animals. Previously, we
showed that supplementation with the SALF resulted in dosedependent inhibition of cervical tumor growth (Lin et al.,
2010b). However, the exact mechanism of the inhibitory effect
on cervical cancer cell growth by the SALF is not well understood. So, understanding the mechanism of the SALF
could lead to improved therapeutic benefits and approaches.
Apoptosis plays a vital role in regulating cell growth and
leads to morphological and biochemical changes (Ghobrial et
al., 2005). In principle, apoptotic mechanisms are often divided into mitochondrial-dependent and -independent pathways. The mitochondrial-independent pathway, also called
the extrinsic-mediated pathway, is activated on cell surfaces of
ligand-gated death receptors that include Fas and death receptors (Ashkenazi and Dixit, 1998; Schmitz et al., 2000).
When ligands trigger extracellular death receptors, such as
CD95, tumor necrosis factor (TNF)-related apoptosis-inducing
ligand (TRAIL)-R1, and TRAIL-R2, the death domains attract
TNF receptor 1-associated death domain (TRADD) proteins
and Fas-associated death domain (FADD) proteins which bind
to cytoplasmic death receptors. It then activates the initiator of
caspases-8 and -10, also called the death-inducing signaling
complex (DISC), through Bid cleavage and induces irreversible cell death (Kischkel et al., 1995; Scaffidi et al., 1998;
Krammer, 1999; Yu et al., 1999; Sprick et al., 2000; Kischkel
et al., 2001; Thorburn, 2004).
On the other hand, the mitochondrial-dependent pathway is
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regulated by caspase activation and mitochondrial pore formation. Caspases play important roles in apoptosis, proliferation, differentiation, and inflammation (Evan and Vousden,
2001; Siegel, 2006). During this process, mitochondrion outer
membranes (MOMs) undergo permeabilization which causes
loss of the mitochondrial membrane potential (MMP) and
releases apoptotic proteins into the cytosol, such as cytochrome
(Cyt) c and apoptosis-inducing factor (AIF) (Rathmell and
Thompson, 1999; Martinou and Green, 2001; Zamzami and
Kroemer, 2001; Savill and Fadok, 2007). MOMs are also
regulated by Bcl-2 family proteins (Youle and Strasser, 2008),
that include Bcl-2 and Bcl-XL, which have antiapoptotic roles
that maintain the integrity of mitochondrial membranes (Vaux
et al., 1998). In contrast, Bak and Bax initiate conformational
changes in MOMs in response to stimulation of cell apoptosis.
This leads to oligomerization of MOMs (Green and Kroemer,
2004). One of the released apoptotic proteins is Cyt c that
binds to apoptotic protease-activating factor (Apaf)-1 (Li et al.,
1997). Caspase-9 then binds to Apaf-1 to form a highmolecular-weight complex called the apoptosome (Zou et al.,
1999). In addition, this interaction activates caspase-3 and
triggers its reversible apoptotic program (Mueller et al., 2003).
In the present communication, we conducted an investigation on the mechanism responsible for inhibiting cervical
cancer cell proliferation and apoptosis using HeLa, HeLa299,
C33A, and Ca ski cell lines as an in vitro cell-culture model.
We report that the SALF induced apoptosis in cervical cancer
cells and mitochondrion-dependent apoptosis cell death in
aggressive cervical cancer cells. We also checked progression
of the deregulated cell cycle in cervical cancer cells. Interestingly, the SALF induced apoptotic cell death of cervical
cancer cells which was mediated through modulation of the
expression levels of pro- and antiapoptotic proteins. Also, the
SALF induced MMP loss and activated caspase-3 and -9 pathways in HeLa cells. Thus, our studies provide insights into
the mechanism by which the SALF induces apoptosis in HeLa
cells.

II. MATERIALS AND METHODS
1. Peptide
The
cyclic
peptide,
the
SALF
(Ac-ECKFTVKPYLKRFQVYYKGRMWCP-NH2), was synthesized and purified by GL Biochemistry (Shanghai, China)
to a purity grade of >95%. Synthetic peptides were reconstituted in phosphate-buffered saline (PBS; pH 7.4) for the experiments.
2. In Vitro Cytotoxicity Assay
Cervical cancer cells were cultured in 96-well plates at 5000
cells per well, and treated with the SALF. PBS treatment
served as a control. At the end of treatment, a mixture (20 l)
of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazinemethosulfate (PMS) (Promega, Mannheim, Germany) was added for
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2 h at 37C. The optical density was measured on a microtiter
plate reader at 570 nm. Experiments were repeated three
times. Results are expressed as a percentage of the inhibition
rate of viable cells, and values of the PBS-treated group were
deducted from the experimental results.
3. Acridine Orange/Ethidium Bromide (Ao/EtBr) Staining
Typical apoptotic cells were detected and stained with
Ao/EtBr. After treatment with the SALF, HeLa cells were
washed with PBS. Then these cells were stained with Ao/EtBr
that used cold DPBS containing 1 μg/ml EtBr and 1 μg/ml Ao
for 15 min at 37C. Double staining can discriminate live cells
from apoptotic and necrotic cells. Cells were washed with
PBS and subsequently observed. Photographs were taken with
a fluorescence microscope.
4. DNA Fragmentation Assay
HeLa cells were cultured in the absence and presence of
the SALF. Cells were collected, and DNA was extracted using
a Suicide Track DNA Ladder Isolation Kit (Calbiochem,
Darmstadt, Germany). DNA fragments were separated by
2% agarose gel electrophoresis, and stained with EtBr. Then,
the DNA fragments were visualized under UV light.
5. Western Blot Analysis
Briefly, 10 g of proteins was loaded on sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE),
transferred to nitrocellulose membranes, and blotted with
primary antibodies reactive to the detected proteins of Cyt c,
AIF, Bid, Bax, Bad, Bim, Bik, Bak, puma, -actin, cyclooxygenase (Cox)-IV, and PCNA, followed by the secondary antibodies of goat anti-rabbit immunoglobulin G (IgG) or antimouse IgG labeled with alkaline phosphatase (AP) for 0.5 h at
room temperature. After three washings with PBS and
Tween-20 (PBS/T) for 10 min, membranes were incubated
with nitroblue tetrazolium-5-bromo-4-chloro-3-indolyl phosphate (NBT-BCIP) in a toluidinium salt substrate at room
temperature.
6. Annexin V and Propidium Iodide (PI) Double Staining
by Flow Cytometry
HeLa cells were cultured in the absence and presence of the
SALF and different caspase inhibitors. Cells were collected
and fixed with ice-cold 70% ethanol at 4C overnight. Cells
were washed with DPBS buffer twice to remove any residual
ethanol. We used annexin V to assess phosphatidylserine (PS)
exposure, and PI for the cell viability analysis. Cells were
analyzed with Gallios software (Beckman Coulter, CA, USA).
7. MMP Detection by Flow Cytometry
Changes in the MMP in HeLa cells after treatment with the
SALF were determined by flow cytometry using 1,1 ́,3,3,3 ́hexamethylindodicarbo-cyanine iodide (DilC1). Detection
followed the instructions of the manufacturer. The monomeric
form emits light at 658 nm after excitation at 633 nm, and
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results were analyzed by Gallios software (Beckman Coulter).

100

8. Cell Cycle Analysis by Flow Cytometry

11. Statistical Analysis
For the statistical analyses, multiple-group comparisons
were evaluated using an analysis of variance (ANOVA) in
SPSS software (Chicago, IL, USA). Differences were defined
as significant at p < 0.05.

III. RESULTS
1. The SALF Exhibited Cytotoxic Properties in Cervical
Cancer Cells
To determine the cytotoxicity of the SALF, human cervical
cells (C33A, Ca ski, HeLa 299, and HeLa cells) were treated
with different dosages of the SALF (0, 25, 50, 100, and 200
g/ml) for 24 h (Fig. 1(a)). Cell inhibitory percentages were
36.41%  4.13%, 52.60%  1.86%, 60.26%  2.95%, and
68.06%  3.71% in C33A, Ca ski, HeLa 299, and HeLa cells
treated with 100 g/ml of the SALF, respectively. Also, we
detected cell inhibitory rates of SALF-treated cells. Cells
showed decreased viability in a time-dependent manner (Fig.
1(b)). We then wanted to know whether or not the cytotoxicity in these cells was caspase-dependent. We used a general
caspase inhibitor (Z-VAD-FMK) to pretreat HeLa cells.
The results showed that the cell inhibition rate significantly
decreased in SALF-induced HeLa cell death (Fig. 1(c)). Cell
inhibitory percentages were 38.08%  4.14%, 29.95% 
4.79%, 28.32%  3.03%, and 22.28%  2.72% in C33A, Ca
ski, HeLa 299, and HeLa cells, respectively. These data
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10. Immunohistochemistry
Tumors were removed, and paraffin sections were created
using primary antibodies of anti-activated caspases-3 and -9
by immunohistochemistry that was performed at the Taipei
Institute of Pathology (http://www.tipn.org.tw/). Photomicrographs were taken under a fluorescence microscope.
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9. Confocal Fluorescence Microscopy
To detect AIF release, samples were treated with the SALF
and imaged with a confocal microscope. Images of AIF
(green) and DAPI (blue) were separately obtained and then
merged.
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In order to determine the effect of the SALF on the cell
cycle, a fluorescence-activated cell-sorting (FACS) analysis
was carried out. For propidium iodide (PI) staining, cells were
seeded in 6-well plates at a density of 104 cells/ml. After 24 h
of attachment, cancer cells were treated with the indicated
SALF concentrations for different time intervals. Floating and
attached cells were harvested, washed in PBS, fixed in icecold ethanol (70% v/v), and stored at -20C. For analysis,
cells were washed in PBS and suspended in PI (25 mg/ml) in
PBS with RNase A (200 mg/ml). Cells were analyzed by
Gallios software (Beckman Coulter).
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Fig. 1. Effects of the shrimp anti-lipopolysaccharide factor (SALF) on
the viability of different cervical cancer cell lines. (a) Cells (5000
cells/well) in a 96-well dish were cultured overnight and then incubated with different indicated concentrations (0, 25, 50, 100,
and 200 μg/ml) of the SALF for 24 h. Cell viability was determined by an MTS assay. (b) Cells (5000 cells/well) in a 96-well
dish were cultured overnight and then incubated with 100 μg/ml
of the SALF for different times (0, 12, 24, 36, and 48 h). Cell
viability was determined by an MTS assay. (c) Effects of pretreatment with a general caspase inhibitor (Z-VAD-FMK) on the
cytotoxicity of the SALF. Cells (5000 cells/well) in a 96-well dish
were grown overnight, pretreated with 50 μM of a general caspase inhibitor for 2 h, and then incubated with 100 μg/ml of the
SALF in the presence and absence of Z-VAD-FMK for 24 h. Cell
viability was determined as described above.
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Fig. 2. The shrimp anti-lipopolysaccharide factor (SALF) induces cell cycle arrest in cervical cancer cell lines. (a) Cervical cancer cells were incubated
for increasing intervals (12 and 24 h), and DNA distribution was analyzed with propidium iodide staining by flow cytometry. (b) Percentages of
cells in the G0/G1, S, and G2/M phases were calculated. The results are the mean ± SD of three experiments.

suggested that the SALF inhibited cervical cancer cell growth
and induced caspase-dependent apoptosis in Ca ski, HeLa 299,
and HeLa cells.
2. The SALF Arrests Cell-Cycle Progression
In order to examine the cell-cycle distribution in SALFtreated cervical cancer cells, we used flow cytometry to analyze and calculate the percentages of cells in the G0/G1, S, and
G2/M phases. Typical time-dependent G2/M arrest in HeLa
and HeLa 299 cells was observed with 100 g/ml SALF
treatment (Fig. 2(a)). G0/G1 phase DNA contents decreased
from 72.83%  0.06% to 33.27%  1.48%, whereas the G2/M
DNA contents increased from 11.80%  1.73% to 35.80% 
3.33% in HeLa cells. G0/G1 phase DNA contents decreased
from 74.07%  2.15% to 42.27%  0.93%, whereas G2/M
DNA increased from 11.37%  1.46% to 28.80%  0.26% in
HeLa 299 cells (Fig. 2(b)).
3. Characterization of SALF Localization and the Study of
Its Effects on Apoptosis in HeLa Cells
To further characterize localization of the SALF in HeLa

cells, we used the SALF labeled with FITC to study peptide
localization by immunocytochemical staining. We observed
that the SALF was localized in the cytosol of HeLa cells after
24 h of treatment. Accumulation of the SALF increased with
time, especially in areas surrounding nuclei at 72 h (Fig. 3(a)).
These results suggest that the SALF functions like a lytic
peptide which breaks down plasma membranes. In order to
investigate the type of cell death induced by the SALF, cells
were stained with Ao/EtBr. With Ao/EtBr, one can identify
viable, apoptotic, and necrotic cells based on the color and
appearance. Viable cells are green with undamaged nuclei.
Bright-orange chromatin indicates non-viable cells. The appearance of cell shrinkage and DNA with condensation indicates apoptosis. Samples treated with 100 g/ml of the SALF
for 24, 48, and 72 h were stained with Ao/EtBr, and we observed that cell shrinkage and DNA with condensation appeared in SALF-treated HeLa cells at 24 h (Fig. 3(b)). To
further characterize the end stage of apoptosis induced by
the SALF, we examined whether treatment with the SALF
induced a typical ladder pattern of inter-nucleosomal DNA
fragmentation in HeLa cells. As shown in Fig. 3(c), DNA
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Fig. 3. The shrimp anti-lipopolysaccharide factor (SALF) induced apoptosis in HeLa cells. (a) We studied the distribution of the SALF coupled with
FITC after HeLa cells were treated with the SALF for 24, 48, and 72 h. The green signal indicates FITC-labeled SALF, while the blue signal
indicates nuclei. (b) Identification of apoptotic HeLa cells using acridine orange-ethidium bromide (Ao/EtBr) staining and the effect induced
by the SALF at 24, 48, and 72 h. (c) Cells were treated with the SALF (0, 50, and 100 μg/ml), and genomic DNA was extracted and resolved on
2% agarose gels. Apoptotic DNA fragmentation was visualized by EtBr staining.

fragmentation was observed after treating HeLa cells with the
SALF, and it was found to occur in a dose-dependent manner.
These data suggest that the SALF induces apoptosis in HeLa
cells.
4. Apoptosis of SALF-Induced HeLa Cells Requires
Caspase Activities
To further confirm the involvement of caspases in SALFinduced apoptosis, we used various caspase inhibitors that
completely blocked activation of their corresponding caspases.
Those inhibitors were BAPTA (a calcium chelator), NAC (a
reactive oxygen species inhibitor), Z-VAD-FMK (a broad caspase inhibitor), Z-DEVD-FMK (a specific caspase-3 inhibitor),
Z-IETD-FMK (a specific caspase-8 inhibitor), and Z-LEHDFMK (a specific caspase-9 inhibitor). We found that Z-VADFMK, Z-LEHD-FMK, and Z-DEVD-FMK significantly suppressed SALF-induced apoptosis. Survival percentages were
41.02%  3.26%, 87.99%  5.08%, 73.01%  9.37%, and
70.57%  5.31% in groups of only SALF-treated HeLa cells,
Z-VAD-FMK pretreatment, Z-LEHD-FMK pretreatment, and
Z-DEVD-FMK pretreatment, respectively. However, the sur-

vival percentage was 38.65%  3.95% in the group with
Z-IETD-FMK pretreatment (Fig. 4(a)). Similarly, pretreatment with Z-VAD-FMK, Z-LEHD-FMK, and Z-DEVD-FMK
attenuated SALF-induced apoptotic phenomena (Fig. 4(b)).
Apoptotic percentages were 78.57%  5.35%, 69.03% 
14.22%, 29.43%  20.41%, and 28.43%  7.92% in the group
of only SALF-treated HeLa cells, Z-IETD-FMK pretreatment,
Z-DEVD-FMK pretreatment, and Z-LEHD-FMK pretreatment, respectively (Fig. 4(c)). Those results indicate that the
SALF activated caspases-3 and -9, but not caspase-8.
5. The SALF Induced Mitochondrial Membrane
Depolarization Associated with AIF Translocation
to Nuclei and Modulated Expressions of Bcl-2 Family
Proteins in HeLa Cells
Activation of caspases-3 and -9 by the SALF suggested
that the mitochondrial apoptotic pathway is involved in SALFinduced apoptosis in HeLa cells. Mitochondria play a key
role in apoptosis induction. Therefore, we investigated the
effects of the SALF on the MMP using DilC1. DilC1 is a
mitochondrion-specific voltage-dependent dye. It can enter
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Fig. 4. The shrimp anti-lipopolysaccharide factor (SALF) induced apoptosis in HeLa cells through a caspase-dependent pathway. (a) Cells were
pretreated with BAPTA (25 μM), NAC (100 μM), Z-DEVD-FMK (100 μM), Z-IETD-FMK (100 μM), Z-LEHD-FMK (100 μM), or Z-VAD-FMK
(50 μM) for 2 h, and then treated with or without the SALF (100 μg/ml) for 24 h. Cell viability was determined by an MTS assay. (b) and (c)
Cells were pretreated with Z-DEVD-FMK (100 μM), Z-IETD-FMK (100 μM), or Z-LEHD-FMK (100 μM) for 2 h, and then treated with or
without the SALF (100 μg/ml) for 24 h. Cells were harvested and co-stained with FITC-conjugated Annexin V and propidium iodide, and the
externalization of phosphatidylserine (PS) was detected using flow cytometry. Data are the mean ± SD from three separate experiments. Differences were defined as significant at p < 0.05. Different letters indicate a significant difference between two groups, while the same letter indicates no difference between two groups.
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(1:1000), rabbit anti-Cox IV (1:1000), mouse anti-cytochrome C (1:1000), or rabbit β-actin (1:104), and then goat anti-mouse or rabbit alkaline
phosphatase (1:104). (d) Cells were treated with different concentrations of the SALF for 24 h and then harvested. Total cell lysates, and mitochondrial and cytosolic fractions were prepared. Equal amounts of protein were separated by 12% SDS-PAGE, transferred to PVDF membranes, and blotted with antibodies specific for Bid, Bax, bad, and bim (at 1:1000). β-Actin and Cox-IV were used as internal controls. (e) Cells
were treated with the SALF and harvested as described above. Equal amounts of protein were separated and blotted with rabbit anti-Apaf-1
(1:1000), rabbit anti-bcl-2 (1:1000), rabbit anti-bcl-xl (1:1000), rabbit anti-bik (1:1000), rabbit anti-bak (1:1000), rabbit anti-puma (1:1000),
and rabbit β-actin (1:104), and then goat anti- rabbit alkaline phosphatase (1:104). (f) Immunofluorescence confocal microscopy was carried
out using anti-AIF to observe translocation of the AIF in HeLa cells. Nuclei were stained with DAPI.
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mitochondria of healthy cells but leaches into the cytosol of
cells with MMP dissipation, resulting in a decreased fluorescence intensity. CCCP was used to induce mitochondrial
membrane depolarization. As shown in Fig. 5(a), mitochondrial membrane depolarization was visible at 24 h after treatment with 100 g/ml of the SALF. Percentages of the mitochondrial transmembrane potential were 94.01%  2.13%,
65.10%  2.81%, 87.02%  3.09%, and 50.63%  5.05% in
the control, CCCP, the SALF at 50 g/ml, and the SALF at 100
(g/ml) groups, respectively (Fig. 5(b)). These data suggest
that SALF-induced caspase-9 and -3 activation occurs after
loss of the MMP in HeLa cells. In order to further analyze
whether the SALF affected the release of Cyt c or AIF during
apoptosis, we evaluated protein expressions of Cyt c and AIF
by Western blotting. We found that the level of cytosolic Cyt c
was dose-dependently elevated in SALF-treated HeLa cells,
but the level of mitochondrial Cyt c was degraded. Also, AIF
was dose-dependently transferred from mitochondria to the
cytosol and even into nuclei of HeLa cells exposed to the
SALF (Fig. 5(c)). Similarly, immunofluorescence confocal
microscopy was used to determine the release of AIF by HeLa
cells (Fig. 5(f)). Bcl-2 family proteins maintain a balance
between pro- and antiapoptotic members. They are known to
control apoptosis that occurs via the mitochondrial pathway.
We also examined the effects of the SALF on levels of Bcl-2
family proteins in HeLa cells. Our results showed that the
SALF decreased cytosolic levels, but increased mitochondrial levels of the proapoptotic bax, bad, and bim (Fig. 5(d)).
However, we found no changes in bid, bik, bak, or puma
protein levels. On the other hand, levels of Bcl-2 and bcl-xl
were reduced and Apaf-1 increased after SALF treatment (Fig.
5(e)). These findings suggest that the SALF modulates protein
levels of Apaf-1, bax, bad, bim, Bcl-2, and bcl-xl in MMP loss
and the release of Cyt c and AIF from mitochondria.
6. Detection of Apoptotic Cells in Nude Mice Using
Activated Caspase-3 and Caspase-9
Immunohistochemistry
To verify the effect of activated caspases-3 and -9 on
SALF-treated HeLa cells in a mouse model, we administered
the SALF and determined whether it dose-dependently increased cell apoptosis (Figs. 6(a) and (b)).

IV. DISCUSSION
Important resources of anticancer agents are many marine-derived substances which were shown to have various
bioactivities. For example, pardaxin from the Red Sea Moses
sole was reported to inhibit growth of HeLa and HT1080 cells
(Hsu et al., 2011; Huang et al., 2011c). Also, epinecidin-1 and
TH1-5 respectively from Epinephelus coioides and Oreochromis mossambicus have antitumor activity (Lin et al., 2009;
Chang et al., 2011). Moreover, many marine-derived substances have antibacterial and immunomodulatory activities
(Huang et al., 2011a; Huang et al., 2011b; Pan et al., 2009; Pan
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Fig. 6. The shrimp anti-lipopolysaccharide factor (SALF) activated
caspase-3 and caspase-9 immunohistochemistry tumor growth in
vivo. Paraffin sections were immunostained with antibodies that
specifically detected activated caspases-3 and -9.

et al., 2010; Rajanbabu and Chen, 2011; Rajanbabu et al., 2010).
Interestingly, it was reported that one of the marine-derived
substances is an AMP, the SALF, that has various bioactivities,
such as antibacterial, anti-parasitic, and anti-inflammatory
responses and antitumor activities (Lin et al., 2010a; Lin et al.,
2010b; Pan et al., 2007; Pan et al., 2009; Pan et al., 2010).
However, the molecular mechanism involved in SALFinduced apoptosis is poorly understood. It has been reported
that positively charged AMPs bind to cell plasma membranes
containing negatively charged phospholipids such as PG or PS
due to strong electrostatic interactions (Melo et al., 2009).
Base on this theory, AMPs can disrupt membrane through different mechanisms such as barrel stave, carpet, and toroidal
pore. In the barrel stave mechanism, AMPs aggregate in the
membrane and form transmembrane pores. In the carpet
mechanism, AMPs align parallel to bilayer and produce a
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detergent-like effect so that AMPs can disrupt the membrane.
The toroidal pore mechanism is similar with barrel stave
mechanism.
In this study, the mechanism of cell death induced by the
SALF in cervical cancer cells was characterized to confirm its
potential use as an anticancer treatment option. We demonstrated in this study that the SALF is a cell cycle modulator
which arrests the cell cycle at the G2/M phase (Fig. 2). We
also evaluated synthetic SALF compounds as potential therapeutics for cervical cancer (Figs. 1(a) and (b)). Apoptosis
was observed at 24 h after SALF treatment (Fig. 3(b)). In
addition, Z-VAD-FMK, Z-DEVD-FMK, and Z-LEHD-FMK
potently prevented SALF-induced apoptosis. These results
indicated that caspase family members are significantly
activated following SALF treatment. Furthermore, we also
proved that the SALF could increase expressions of activated
caspases-3 and -9 by immunohistochemical tumor growth in
vivo (Fig. 6). These data indicated that the SALF induced
apoptosis in cervical cancer cells through activating a caspase-3 and -9-dependent pathway, resulting in loss of the
MMP, and Cyt c and AIF release (Figs. 5-7). In addition, it has
been reported that AMP can activate apoptosis inducing factor
and induce DNA damage in cancer cells (Ren et al., 2012).
Also, we first found that SALF (shrimp AMP) can suppress
cervical cancer via apoptosis inducing factor and DNA damages. In Fig. 3(c), we examined dose-dependently DNA fragmentation after treating HeLa cells with the SALF. Also, AIF
was transferred from mitochondria to the cytosol in a dosedependent manner and even into nuclei of HeLa cells exposed
to the SALF in Fig. 5(c). AIF is normally in mitochondria of
healthy cells. However, it can be released into the cytosol and
nuclei, resulting in DNA fragmentation during apoptosis
(Susin et al., 1999). Cyt c is also an apoptogenic factor that
resides in mitochondrial intermembrane spaces. It acts by
forming an apoptosome with Apaf-1 and activated caspase-9
(Li et al., 1997; Zou et al., 1997; Riedl and Salvesen, 2007; Lu
et al., 2012). Besides, ROS levels can increase during early
apoptotic pathway. ROS also triggers cytochrome c (Cyt c)
and AIF releasing from mitochondria (Cregan et al., 2004).
Our data showed that the levels of cytosolic Cyt c and AIF
were elevated in SALF-treated HeLa cells, but the levels of
mitochondrial Cyt c and AIF were degraded (Fig. 5(c)). In
addition, the survival percentage of NAC (a reactive oxygen
species inhibitor)-preteated group was increased, compared
with SALF-treated group (Fig. 4(a)). Therefore, we inferred
that ROS might relate with SALF-treated HeLa cells that
went through early apoptotic pathway. The X-linked inhibitor of apoptosis (XIPA) directly inhibits caspases-3 and
-9 and mediates their ubiquitination and degradation (Deveraux et al., 1997; Huang et al., 2001; Eckelman et al., 2006).
Our investigations showed that the SALF also modulated
pro- and antiapoptotic proteins that control apoptosis. The
balance between them is critical for cell survival and death.
The SALF promoted apoptotic protein expression (Bax,
Bad, and Bim) from the cytosol to mitochondria and sup-

SALF
bad
bim

mitochondria

bax

cytochrome C
AIF
Bcl-2
Bcl-xL
pro-caspase 9

caspase 9

Apaf-1

nucleus

apoptosis
Fig. 7. Schematic representation of the signaling cascade of shrimp antilipopolysaccharide factor (SALF)-induced HeLa cell apoptosis.

pressed antiapoptotic protein expressions (Bcl-2 and Bcl-XL)
(Figs. 5(d) and (e)). The results suggested that changes in
the ratio of pro- and antiapoptotic proteins might contribute
to the proapoptotic activity of the SALF. Taken together, these
results suggest that SALF treatment generates signature
morphologic characteristics of apoptosis in mitochondria in a
caspase-3 and -9-dependent manner (Fig. 7).

V. CONCLUSION
In conclusion, the SALF is a peptide that effectively inhibits cellular growth of cervical cancer cells. In the present
study, we showed that the SALF mediated both caspase- and
mitochondria- dependent pathways during SALF-induced
apoptosis in human cervical cancer cells. Our data suggest
that the SALF not only induced cervical cancer cell death and
cell cycle arrest in G2/M phase in vitro, but also increased
activated caspase-3 and -9 in vivo. To sum up, our study provides evidence from molecular studies which shows that the
SALF induced the death of human cervical cancer cells. It
can improve therapeutic benefits and provide alternative approaches for treating cervical cancer.
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